Copenhagen, Denmark Friday, December 20, 2024, 10:00 Hrs [IST] ...

Diabetes is a global health issue that continues to rise, including in Thailand. In 2021, 537 million people worldwide were ...

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...

Danish pharmaceutical company Novo Nordisk recently announced plans to spend approximately $1.2 billion to build a new ...

With U.S. headquarters in Plainsboro, Novo Nordisk told NJBIZ, "NAION is a very rare eye disease, and it is not an adverse ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

LONDON— A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly "opens the possibility of an end to the ...